[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2223002A1 - - Google Patents

Info

Publication number
FR2223002A1
FR2223002A1 FR7411408A FR7411408A FR2223002A1 FR 2223002 A1 FR2223002 A1 FR 2223002A1 FR 7411408 A FR7411408 A FR 7411408A FR 7411408 A FR7411408 A FR 7411408A FR 2223002 A1 FR2223002 A1 FR 2223002A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7411408A
Other languages
French (fr)
Other versions
FR2223002B1 (el
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP48037205A external-priority patent/JPS5939439B2/ja
Priority claimed from JP48073898A external-priority patent/JPS5852997B2/ja
Priority claimed from JP13936473A external-priority patent/JPS5716118B2/ja
Priority claimed from JP741096A external-priority patent/JPS5734837B2/ja
Priority claimed from JP1308374A external-priority patent/JPS5732074B2/ja
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of FR2223002A1 publication Critical patent/FR2223002A1/fr
Application granted granted Critical
Publication of FR2223002B1 publication Critical patent/FR2223002B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
FR7411408A 1973-03-30 1974-03-29 Expired FR2223002B1 (el)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP48037205A JPS5939439B2 (ja) 1973-03-30 1973-03-30 ７−置換−３−ｎ，ｓ含有複素環チオメチル−３−セフエム−４−カルボン酸誘導体の製造法
JP48073898A JPS5852997B2 (ja) 1973-06-29 1973-06-29 ７− チカン −３− ヒドロキシアルキルチカンフクソカンチオメチル −３− セフエム −４− カルボンサンルイノ セイゾウホウ
JP13936473A JPS5716118B2 (el) 1973-12-12 1973-12-12
JP741096A JPS5734837B2 (el) 1973-12-26 1973-12-26
JP1308374A JPS5732074B2 (el) 1974-01-30 1974-01-30

Publications (2)

Publication Number Publication Date
FR2223002A1 true FR2223002A1 (el) 1974-10-25
FR2223002B1 FR2223002B1 (el) 1977-11-04

Family

ID=27518056

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7411408A Expired FR2223002B1 (el) 1973-03-30 1974-03-29

Country Status (10)

Country Link
AR (1) AR207752A1 (el)
BE (1) BE812951A (el)
CH (3) CH595388A5 (el)
DE (1) DE2415402C2 (el)
FR (1) FR2223002B1 (el)
GB (1) GB1461948A (el)
NL (1) NL180422C (el)
NO (2) NO741137L (el)
NZ (1) NZ173837A (el)
SE (1) SE428297B (el)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2322603A1 (fr) * 1975-09-02 1977-04-01 Smithkline Corp Nouvelles cephalosporines, leur procede de preparation et leurs applications pharmaceutiques
FR2351982A1 (fr) * 1975-10-30 1977-12-16 Smithkline Corp Derives de cephalosporine
FR2361404A1 (fr) * 1976-07-12 1978-03-10 Smithkline Corp Nouvelles 7-boxyiminoacylcephalosporines, leurs procedes de preparation et leur application en therapeutique
FR2370053A1 (fr) * 1976-11-04 1978-06-02 Smithkline Corp Acides 7-acylamino-3-(1-(2,3-dihydroxypropyl)tetrazole-5-ylthiomethyl)-3-cepheme-4-carboxyliques et leur application en therapeutique
EP0000100A1 (en) * 1977-06-09 1978-12-20 Smithkline Beckman Corporation 7-Acylamino-3-(1-(2-sulfamoylaminoethyl)-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acids, a process for their preparation and compositions containing them

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379924A (en) 1973-12-25 1983-04-12 Takeda Chemical Industries, Ltd. Cephalosporin derivatives
US4093723A (en) 1976-05-19 1978-06-06 Smithkline Corporation 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl) cephalosporins
US4171362A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Acylamino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins antibacterial compositions containing them and methods of treating bacterial infections with them
US4171433A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Amino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporin intermediates for preparing 7-acylamino cephalosporins
US4171368A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Acylamino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
US4118491A (en) * 1976-03-11 1978-10-03 Smithkline Corporation 7-Acyl-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
US4101656A (en) 1976-07-12 1978-07-18 Smithkline Corporation 7β-Acylamino-3-(alkanesulfonamidoalkyl substituted tetrazolylthiomethyl) cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
US4083975A (en) 1976-09-24 1978-04-11 Smithkline Corporation 7-Acylamino-3-(3-sulfomethyl-1,2,4-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acids
WO2001044186A1 (fr) * 1999-12-16 2001-06-21 Sumitomo Pharmaceuticals Company, Limited Derives de guanidine substitues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
DE1953861C2 (de) * 1969-10-25 1982-12-23 Fujisawa Pharmaceutical Co., Ltd., Osaka 7-Tetrazolylacetamido-3-thiomethyl-3-cephem-4- carbonsäuren
US3757014A (en) * 1971-05-07 1973-09-04 Bristol Myers Co Ts 1,3,4 - oxadiazol-2-yl)thiomethyl)-3-cephem-4-carboxylic acid and sal7-(d-(alpha-amino-alpha-pheyle-acetamido)) - 3-(s-(5-hydroxymethyl -
CA999574A (en) 1972-06-14 1976-11-09 Smith Kline And French Canada Ltd. 7-hydroxyhalophenylacetamido-3-h heterocyclicthiomethyl cephalosporins

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2322603A1 (fr) * 1975-09-02 1977-04-01 Smithkline Corp Nouvelles cephalosporines, leur procede de preparation et leurs applications pharmaceutiques
FR2351982A1 (fr) * 1975-10-30 1977-12-16 Smithkline Corp Derives de cephalosporine
FR2361896A1 (fr) * 1975-10-30 1978-03-17 Smithkline Corp Nouveaux derives de la cephalosporine, leur procede de preparation et leur application comme medicament
FR2361404A1 (fr) * 1976-07-12 1978-03-10 Smithkline Corp Nouvelles 7-boxyiminoacylcephalosporines, leurs procedes de preparation et leur application en therapeutique
FR2370053A1 (fr) * 1976-11-04 1978-06-02 Smithkline Corp Acides 7-acylamino-3-(1-(2,3-dihydroxypropyl)tetrazole-5-ylthiomethyl)-3-cepheme-4-carboxyliques et leur application en therapeutique
EP0000100A1 (en) * 1977-06-09 1978-12-20 Smithkline Beckman Corporation 7-Acylamino-3-(1-(2-sulfamoylaminoethyl)-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acids, a process for their preparation and compositions containing them

Also Published As

Publication number Publication date
CH610903A5 (en) 1979-05-15
NL180422C (nl) 1987-02-16
BE812951A (fr) 1974-09-30
NL180422B (nl) 1986-09-16
GB1461948A (en) 1977-01-19
SE428297B (sv) 1983-06-20
NO801402L (no) 1974-10-01
FR2223002B1 (el) 1977-11-04
SE7404306L (el) 1974-10-01
CH595388A5 (el) 1978-02-15
NZ173837A (en) 1978-07-28
NL7404330A (el) 1974-10-02
DE2415402C2 (de) 1985-12-19
DE2415402A1 (de) 1974-10-03
AR207752A1 (es) 1976-10-29
AU6735374A (en) 1975-10-02
CH610902A5 (en) 1979-05-15
NO741137L (no) 1974-10-01

Similar Documents

Publication Publication Date Title
AR201758A1 (el)
AU476761B2 (el)
AU465372B2 (el)
AR201235Q (el)
AR201231Q (el)
AU474593B2 (el)
AU474511B2 (el)
AU474838B2 (el)
AU471343B2 (el)
AU465453B2 (el)
AU465434B2 (el)
AU450229B2 (el)
AU476714B2 (el)
AR201229Q (el)
AU466283B2 (el)
AU476696B2 (el)
AU472848B2 (el)
AR199451A1 (el)
AU477823B2 (el)
AR197627A1 (el)
AU477824B2 (el)
AR200256A1 (el)
AU461342B2 (el)
AR210729A1 (el)
AR195311A1 (el)

Legal Events

Date Code Title Description
ST Notification of lapse